Literature DB >> 15100728

[Angiotensin II-induced podocyte apoptosis: role of the MAPK subtypes].

Xiao-xi Lai1, Guo-hua Ding, Cong-xin Huang, Ming Shi, Cheng Chen.   

Abstract

OBJECTIVE: To evaluate the role of the MAPK subtypes (p38MAPK, ERK and JNK) in ANG II-induced apoptosis of cultured human podocytes.
METHODS: The cultured podocytes were incubated in media containing either vehicle, SB202190(5 micromol/L, an inhibitor of p38MAPK), PD98059 (1 micromol/L, an inhibitor of ERK), SP600125 (5 micromol/L, an inhibitor of JNK), ANG II (10(-8)mol/L) with or without SB202190 PD98059 and SP600125 for 18 hours; the cells were assayed for apoptosis by morphologic staining with H-33342 and propidium iodide and DNA fragmentation assays; the cell proteins were probed for phosphorylated MAPKs to determine the activation of specific MAPK subtypes.
RESULTS: ANG II promoted podocyte apoptosis in a time- and dose-dependent manner; ANG II stimulated p38MAPK, but inhibited JNK; SB202190 inhibited both ANG II-induced podocyte apoptosis and p38MAPK phosphorylation; Inhibition of ERK by PD98059 had no effect on ANG II-induced cell apoptosis.
CONCLUSION: ANG II-induced apoptosis through stimulation of p38MAPK and inhibition of JNK in human podocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100728

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  2 in total

1.  Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement.

Authors:  Mamon Dey; Aleksander Baldys; Dezmond B Sumter; Pal Göoz; Louis M Luttrell; John R Raymond; Monika Göoz
Journal:  J Pharmacol Exp Ther       Date:  2010-06-21       Impact factor: 4.030

2.  Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways.

Authors:  Cheng Chen; Wei Liang; Junya Jia; Harry van Goor; Pravin C Singhal; Guohua Ding
Journal:  Nephron Exp Nephrol       Date:  2009-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.